News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?
Jul 29, 2024, 02:27

Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?

Leandro Jonata Oliveira, Medical Oncologist at Grupo Oncoclinicas,  shared a poll on X:

“Tapestry Study: screening using exome Sequencing identified 32% of HBOC and 56% of Lynch Syndrome carriers who did not meet NCCN criteria for genetic testing (GT).

In the scenario of unrestricted access to GT and couseling, would you recommend universal germline GT for patients with cancer?
  • Yes
  • Not
  • Not yet

‘Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations published in JCO Precision Oncology’

Autors: N. Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L. Bublitz, Lorelei A. Bandel, Sebastian M. Armasu, Robert A. Vierkant, Matthew J. Ferber, Eric W. Klee, Nicholas B. Larson, Teresa M. Kruisselbrink, Jan B. Egan, Jennifer L. Kemppainen, Jessa S. Bidwell, Jennifer L. Anderson, Tammy M. McAllister, T’Nita S. Walker, Katie L. Kunze, Michael A. Golafshar, Margaret A. Klint, Richard J. Presutti, William V. Bobo, Aleksander Sekulic, Jolene M. Summer-Bolster, Cheryl L. Willman, and Konstantinos N. Lazaridis.”

Leandro Jonata Oliveira

Source: Leandro Jonata Oliveira/X

Aleksander Sekulic cancer Cheryl L. Willman Emily Gay Eric W. Klee exome Sequencing identifies Jan B. Egan Jennifer L. Anderson Jennifer L. Kemppainen Jessa S. Bidwell Jolene M. Summer-Bolster Katie L. Kunze Konstantinos N. Lazaridis Leandro Jonata Oliveira Lorelei A. Bandel Lynch Syndrome Margaret A. Klint Matthew J. Ferber Michael A. Golafshar Michelle L. Bublitz N. Jewel Samadder NCCN Nicholas B. Larson OncoDaily Oncology Richard J. Presutti Robert A. Vierkant Sebastian M. Armasu T'Nita S. Walker Tammy M. McAllister Teresa M. Kruisselbrink Vanda Lindpere William V. Bobo
Special Coverage
Blog
Nov 1, 2024, 20:27
Amy Oxentenko: Honored to be inducted as President of the American College of Gastroenterology
Blog
Nov 1, 2024, 20:22
Yan Leyfman: Honored to present our research at the 2024 Lymphoma, Leukemia and Myeloma Congress
Blog
Nov 1, 2024, 20:05
The Official Programme for Advancing Paediatric Oncology on Children’s Rights Day is Out - SIOP Europe
Blog
Nov 1, 2024, 19:20
Chandler Park: Dr. Petros Grivas answers the most important question for junior faculty
Blog
Nov 1, 2024, 19:12
ESTRO: Toxicity Profile of Immune Therapy Combined with Radiotherapy
Insight
Nov 1, 2024, 17:59
Ajay Major: Collect long-term follow-up data in survivors of Hodgkin lymphoma with the MyHodgkin MyHealth app
Blog
Nov 1, 2024, 17:52
Habib Nehmé: Strengthening Presence in Saudi Arabia’s Radiotherapy and Oncology Market
Blog
Nov 1, 2024, 17:46
Hidehito Horinouchi: Early Stage NSCLC at ACLC24 session
Blog
Nov 1, 2024, 17:41
Yelak Biru's interview with News 9 about the work IMF does
Insight
Nov 1, 2024, 17:31
Francisco Esteva: ADCs are making waves in the fight against advanced HER2+ breast cancer
Blog
Nov 1, 2024, 17:27
Alcohol consumption increases the risk of cancer at 7 sites - IARC
Blog
Nov 1, 2024, 17:17
Raul Cordoba: Valemetostat for relapsed or refractory peripheral T-cell lymphoma